Studies on three continents could have broad implications for HIV prevention research
Enrolment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV
Enrolment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV
WHAT: Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with